% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • Jan 2, 2013 8:17 PM Flag

    Smart Consensus/Thompson Reuters

    Have upgraded opinions from avoid/sell to Hold as of today. Those are good indicators from conservative analyst reports considering ARNA has yet to put product on the shelf. Its the potential of the product that is driving improvements in price speculation. We'll see if Standard and Poor's/ Market Edge adjust thier outlooks before weeks end.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree. I got the 1/1/2013 Thompson Reuters Report. It shows "Hold" rating for the First Call Mean (FC) which is the mean recommendation of all analysts covering the stock (10 Analysts).
      However, Verus Opinion is a "BUY" which is provided by Verus Analytics Inc. It is
      an empirically-derived and historically back-tested stock rating system with buy, sell, and hold opinions.

      Sentiment: Buy

    • I saw that too, on my Etrade account. Also an upgrade from SmartConsensus:

      What is SmartConsensus?
      SmartConsensus is a rating based on a universe of companies covered by a team of research providers known as “Constituents” – Thomson Reuters, Standard & Poor’s and MarketEdge. Detailed analysis is performed on each constituent’s own ratings, historical track records and methodologies to identify the areas of strength for each constituent. These strengths are then factored into the ratings generation process to create an overall team rating (“SmartConsensus”) for each company covered.

      Upgraded 5 Days 0.0%
      from Sell on 12/28/12
      That is good news that can convince new investors to take a good look at ARNA.


      Sentiment: Strong Buy

1.750.00(0.00%)Sep 30 4:00 PMEDT